-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Amylyx Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2021 to Q2 2024.
- Amylyx Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $3.59M, a 5.78% decline year-over-year.
- Amylyx Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $15.4M, a 46.2% increase year-over-year.
- Amylyx Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $15.5M, a 314% increase from 2022.
- Amylyx Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $3.74M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)